Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they could rally this year.

H.C. Wainwright has recently initiated Nektar Therapeutics (NKTR) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 4, 2024, Piper Sandler had initiated ...

BTIG Research has recently reduced Vuzix Corp (VUZI) stock to Neutral rating, as announced on November 10, 2023, according to Finviz. Earlier, on December 21, 2021, Dawson James had initiated the ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...

The industry should save on interest expenses this year as it follows the Fed's lead in cutting rates. The downside is that ...

BTIG analyst Jake Fuller says that while Uber‘s (UBER) commentary on its U.S. rideshare business “felt constructive” at intra-quarter appearances, ...

Shares of Birkenstock Holding plc (NYSE:BIRK – Get Free Report) have received an average rating of “Moderate Buy” from the ...

BTIG analyst Marie Thibault reiterated a Buy rating on Outset Medical (OM – Research Report) today and set a price target of $4.00. The ...

Research analysts at Zacks Research boosted their Q3 2025 earnings estimates for Darden Restaurants in a research report issued to clients and investors on Thursday, January 2nd. Zacks Research ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...